Why do I treat my patients with mild hepatitis C?

Why do I treat my patients with mild hepatitis C?

Item
http://www.wikidata.org/entity/Q38685564
Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.How hepatitis C patients manage the treatment process of pegylated interferon and ribavirin therapy: a qualitative study.Extrahepatic manifestations of HCV: the role of direct acting antivirals.Emerging biological agents for hepatitis C.Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis.Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway.Comment on Nuño Solinís R, et al. "Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence".Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C.
P2860

Why do I treat my patients with mild hepatitis C?

Item
http://www.wikidata.org/entity/Q38685564
description
2016 nî lūn-bûn
@nan
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
name
Why do I treat my patients with mild hepatitis C?
@en
type
label
Why do I treat my patients with mild hepatitis C?
@en
prefLabel
Why do I treat my patients with mild hepatitis C?
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P698
P356
P1433
P1476
Why do I treat my patients with mild hepatitis C?
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P698